Supplemental Procedures

In vitro neuronal differentiation of iPSCs
NPCs were generated as previously described with appropriated optimization (Marchetto et al., 2010) . Briefly, iPSCs were dissociated in cell clusters using Accutase (Sigma-Aldrich) and seeded onto low-adhesion plates in mTeSR1 supplemented with N2 (1:200, ThermoFisher Scientific), Pen/Strept (1%, Sigma-Aldrich), human Noggin (0.5 µg/ml, R&D System), SB431542 (5 µM, Sigma-Aldrich) and Y27632 (10 µM, Milteny Biotec). After 10 days, embryoid bodies were seeded onto matrigel-coated plates (1:100, matrigel growth factor reduced, Corning) in DMEM/F12 (Sigma-Aldrich) supplemented with N2 (1:100), non-essential amino acids (1%, MEM NEAA, ThermoFisher Scientific) and Pen/Strept. After 10 days, rosettes were dissociated with Accutase and plated onto matrigel coated-flasks in NPC media containing DMEM/F12, N2 (1:200), B27
(1:100, ThermoFisher Scientific), Pen/Strept (1%) and FGF2 (20 ng/ml, ThermoFisher Scientific).
For differentiation, NPCs were dissociated with Accutase and plated on matrigel-coated 24-well plates (1× 20000 cells per well) in NPC medium. Two days after, the differentiation medium containing Neurobasal (ThermoFisher Scientific), Pen/Strep (1%), B27 (1:50), Sonic Hedgehog (50 ng/ml, Sigma-Aldrich) and CHIR99021 (0,8 µM, Stemgent) was added and kept for 11 days.
During this period half medium was replaced every 2-3 days. After 11 days the differentiation medium was replaced with Neurobasal, Pen/Strep (1%), B27 (1:50), human BDNF (10 ng/ml, PeproTech), human GDNF (10 ng/ml, PeproTech), Forskolin (10 µM, Sigma-Aldrich), Ascorbic Acid (20 µM, Sigma-Aldrich) and Purmorphamine (200 nM, Stemgent) for terminal differentiation.
At this stage half of the medium was changed every 2-3 days.
RNA isolation and real-time RT-PCR
RNA was extracted using the TRI Reagent isolation system (Sigma-Aldrich) according to the manufacturer's instructions. Total RNA was treated with DNAseI (Roche) to prevent DNA contamination. One microgram of RNA was reverse transcribed using the iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad, USA). Quantitative RT-PCR (qRT-PCR) was carried out using the CFX96 Real-Time PCR Detection System (Bio-Rad, USA). One-fiftieth of the reverse-transcribed cDNA was amplified in a 16µl reaction mixture containing 1× Titan Hot Taq EvaGreen qPCR Mix (Bioatlas, Estonia) and 0.4 mM of each primer. The thermal profile consisted of 2 minutes at 50°C and 10 minutes at 95°C, followed by 40 cycles of 15 seconds each at 95°C and 1 minute at 60°C. mRNA levels were calculated according to the threshold cycle numbers within a linear range of amplification of 20 to 32 cycles. Data were standardized versus the housekeeping gene Actin, which was used as an internal standard and amplified for every sample in parallel assays.
Mitotracker Green and Orange
NPCs from patients and controls were incubated with 50 nM of Mitotracker Green and Mitotracker Orange (Molecular Probes) for 30 min at 37 °C, washed with PBS and acquired by confocal microscope (Leica TCS SP5, Germany). For the analysis, the samples were acquired on LSRFortessa (BD) flow cytometer. All data were analyzed using FCS Ex4press 6 Flow (De Novo Software) and expressed as mean fluorescence intensity.
Lysotracker Red
NPCs from patients and controls were incubated with 50 nM of Lysotracker Red (Molecular Probes) for 30 min at 37 °C, washed with PBS and acquired by confocal microscope (Leica TCS SP5, Germany). The quantification of the signal was performed using ImageJ software (NIH, USA).
Mitochondrial Morphology
NPCs from patients and controls were dissociated with Accutase and plated on matrigel-coated 24-well plates (1x40000 cells per well) in NPC medium. Mitochondrial morphology was assessed by TOMM20 immunostaining. Cellular fluorescence images were acquired with a Nikon Eclipse Ni microscope. Images were collected using a X63/1.4 oil objective and analyzed using MitoMorphology macro in ImageJ.
Micro-oxygraphy assays
The day before analysis, NPCs from patients and normal donors were dissociated with Accutase and plated at a density of 20.000 cells per well in a Polyornithine-Laminin coated 96-well multiwell plate and incubated over night at 37°C with 5% CO 2 . After 24 hours, 25mM glucose was added in the medium to perform the subsequent analysis. Drugs were added sequentially to the cells in the following order: Oligomycin 1 µM (Sigma-Aldrich), FCCP (Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone) 2,1 µM (Sigma-Aldrich) and Rotenone 0,5 µM (SigmaAldrich). Measurements were done with Seahorse XFe96 Analyzer (Agilent, USA) and normalized on cell counts, calculated with CyQuant Direct Cell Proliferation Assay Kit (Life Technologies).
Mitochondrial DNA sequencing and quantification
Total DNA from cells was extracted using the NucleoSpin Tissue kit (Machery & Nagel), following manufacturer's instructions. The entire mtDNA molecule was sequenced by NGS approach. First, mtDNA was amplified in two long PCR amplicons (9.1 kb and 11.2 kb) using Q5 High-Fidelity DNA Polymerase (New England Biolabs, UK) and purified by Agencourt AMPure XP (Beckman Coulter Life Sciences, Italy). Subsequently, the library was constructed by Nextera XT DNA Library Preparation Kit (Illumina, San Diego, CA) and sequenced on MiSeq System (Illumina, San Diego, CA), using the 600-cycle reagent kit. All changes are relative to the revised Cambridge Reference Sequence (rCRS, NC_012920). Quantitative Real Time PCR was used to assess mtDNA content per cell, using a previously described method (Mussini et al., 2005) .
RNA sequencing and bioinformatics analysis
Total RNA isolation was performed with RNeasy Mini Kit (QIAGEN). RNA libraries were generated starting from 1 µg of total RNA extracted using TRIzol (Invitrogen, Life Technologies).
RNA quality was assessed by using a Tape Station instrument (Agilent). To avoid overrepresentation of 3'ends, only high-quality RNA with RNA Integrity Number (RIN) ≥ 8 was used.
RNA was processed according to the TruSeq Stranded mRNA Library Prep Kit protocol. The libraries were sequenced on an Illumina HiSeq 3000 with 150bp paired-end reads using Illumina TruSeq technology. Image processing and basecall were performed using the Illumina Real Time Analysis Software. Fastq files were aligned to the human genome (GRCh38/hg38) by using STAR (Dobin, 2013), a splice junction mapper for RNA-Seq data, together with the corresponding splice junctions Ensembl GTF annotation, using default parameters.
Immunostaining
Cells were seeded on matrigel-coated glass coverslips and they were fixed for 20 min in ice in 4% paraformaldehyde (PFA, Sigma), solution in phosphate-buffered saline (PBS, Euroclone). Then, cells were permeabilized for 30 min in blocking solution, containing 0.5% Triton X-100 (SigmaAldrich) and 10% donkey serum (Sigma-Aldrich), and incubated overnight at 4 °C with the primary antibodies in blocking solution. Then, cells were washed with PBS and incubated for 1 h at room temperature with Hoechst and with secondary antibodies. Brain slices were differently processed.
Briefly, free-floating 50 µm-thick slices were rinsed in PBS and treated for one hour with a blocking solution containing BSA 3% and Triton X 100 0.3% in PBS. After being blocked, the tissue was incubated with the primary antibody diluted with a solution containing BSA 1%, Triton X100 0.3% over night at room temperature. The slices were then incubated with the secondary antibody. The following antibodies were used: anti-OCT4 (1:100, Abcam), anti-SOX2 (1:300, R&D 
Striatal TH quantification
Images were taken with Leica DM4000B at 2.5X magnification and analyzed with Image J (NIH, USA). The striatum boundaries were traced and optical density measured in terms of grey levels for 8-bit images.
4-hydroxynonenal staining and quantification
TH and 4-HNE immunostainings were performed as previously described. Single layer pictures were captured using confocal microscope (TCS SP5, Leica, Germany) at 40X magnification. We Mussini, C., Pinti, M., Bugarini, R., Borghi, V., Nasi, M., Nemes, E., Troiano, L., Guaraldi, G., Bedini, A., Sabin, C., et al. (2005) . Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study. Aids 19, 1627-1633. experiments. *P<0,05; **P<0,01; ***P<0,001. Statistical analysis is performed using one-way ANOVA followed by Tukey post-test. Statistical analysis is performed using one-way ANOVA followed by Tukey post-test. mice (at least 10 cells are analyzed for each mouse). **p < 0.01; ***p < 0.001. Statistical analysis is performed using one-way ANOVA followed by Tukey post-test. Scale bar 60 μm.
